Related Experiment Video
Updated: Oct 4, 2025
11:12
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
13.9K
Mechanical versus biological valve prostheses for left-sided infective endocarditis
Amila Kahrovic1, Philipp Angleitner1, Harald Herkner2
1Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Summary
For patients under 55 with left-sided infective endocarditis, mechanical valve replacement significantly reduces mortality and adverse events compared to biological valves. Further research is recommended to confirm these findings.
Area of Science:
- Cardiac Surgery
- Infective Endocarditis
- Prosthetic Heart Valves
Background:
- Left-sided infective endocarditis poses significant risks.
- Valve replacement is a critical intervention for these patients.
- The choice between mechanical and biological prostheses is debated.
Purpose of the Study:
- To compare outcomes of mechanical versus biological valve prostheses in patients with left-sided infective endocarditis.
- To identify patient subgroups that may benefit more from specific valve types.
Main Methods:
- Retrospective single-centre cohort study of 220 adult patients (2009-2018).
- Analysis of all-cause mortality, combined events (death, stroke, bleeding, reoperation), and re-endocarditis risk.
- Statistical analysis adjusted for relevant risk factors.
Main Results:
- Mechanical valve recipients were younger and had lower surgical risk scores.
- In patients <55 years, mechanical valves were associated with significantly lower all-cause mortality (aHR 0.35) and combined events (aHR 0.38).
- No increased re-endocarditis risk with mechanical valves; annular abscess increased re-endocarditis risk (aHR 3.06).
Conclusions:
- Mechanical valve implantation is associated with superior outcomes in patients <55 years with left-sided infective endocarditis.
- These findings suggest a potential benefit of mechanical valves in younger patients.
- A prospective randomized controlled trial is recommended for confirmation.
Related Concept Videos
01:25Endocarditis I: Introduction
50
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
50
01:18Endocarditis III: Medical Management
33
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
33
01:25Endocarditis II: Clinical Features of Infective Endocarditis
40
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
40
01:26Mitral Stenosis III: Medical Management
34
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
34
01:22Mitral Stenosis I: Introduction
72
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
72
01:22Mitral Valve Prolapse II: Assessment and Management
54
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
54